We supply the world with active pharmaceutical ingredients, enabling our customers to improve their patients’ quality of life.
The PharmaZell Group portfolio brings together proprietary know-how, hands-on innovation and our commitment to uncompromising quality. Since 1909, we’ve built our business with a customer-centric focus and a mutual respect for our employees, partners and the environment. We offer:
A Global Network of Expertise: The Group has production sites and employees in pharmaceutical production markets in Germany, Italy and India.
A Trusted Partnership: We take pride in our long-term customer relationships.
A Solution-Oriented Approach: We are an accessible organization, motivated to make things simpler for customers’ business.
A Competitive offering: We consistently deliver value and attractive pricing.
One Group – Three Offerings
The PharmaZell Group is made up of three core brands – PharmaZell, Farmabios and PharmaChol who supply the pharmaceutical industry with Active Pharmaceutical Ingredients and natural source materials. The Group operates production facilities in Germany, Italy and India and enables its companies to secure the industry’s supply chain as trusted drug substance suppliers. Over 900 people work for the PharmaZell Group worldwide.
Key Group Facts:
- More than €170 million revenue in 2018
- Superb annual growth rate over the last decade
- A strong and competitive industry leader, ranked among the top three producers for most Pharmazell products
- State-of-the-art proprietary, large-scale electrochemical processes
- Proprietary enzymatic route of synthesis for cholic acid derivatives
News and Fairs
The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios
We supply the world with active pharmaceutical ingredients – made possible by our committed employees.
If you’re looking for new challenges and a work environment that is driven by a collaborative culture and committed employees, consider a career with PharmaZell Group. We offer competitive wages, job security and career advancement to develop your talent and skillset. You’ll have the opportunity to pursue ambitious objectives with the support of experienced teams and accessible management.
Flexibility is a key aspect to our success in the ever demanding pharmaceutical industry. We’re looking for people who thrive in a lean environment, with a clear vision and strategy. We believe in transparency and open dialogue – it enables us to work more efficiently.
We are an equal opportunity employer and we value diversity. We are committed to providing an inclusive environment of mutual respect where opportunity is available to all applicants, regardless of race, religion or philosophy of life.